Background: Results of our updated meta-analysis indicate that probiotic supplementation significantly reduces all cause mortality and definite NEC by as much as 60% in preterm neonates, without significant adverse effects. Experts have suggested that the current evidence justifies a change in practice in favour of probiotic supplementation if a suitable product is available. However, many other issues (e.g. pooling data in presence of heterogeneity, pitfalls of trial sequential analysis -TSA, lack of data for ELBW neonates) have been raised to oppose such a change in practice.
